Your browser doesn't support javascript.
loading
The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.
Said, J M; Tsui, R; Borg, A J; Higgins, J R; Moses, E K; Walker, S P; Monagle, P T; Brennecke, S P.
Affiliation
  • Said JM; Department of Perinatal Medicine, The Royal Women's Hospital, Parkville, Australia. jo.said@thewomens.org.au
J Thromb Haemost ; 10(5): 881-6, 2012 May.
Article in En | MEDLINE | ID: mdl-22432640

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parity / Polymorphism, Genetic / Pregnancy Complications / Plasminogen Activator Inhibitor 1 / Fibrinolysis Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Country/Region as subject: Oceania Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2012 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parity / Polymorphism, Genetic / Pregnancy Complications / Plasminogen Activator Inhibitor 1 / Fibrinolysis Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Country/Region as subject: Oceania Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2012 Type: Article Affiliation country: Australia